| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.019 | 0.7 |